A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk

BACKGROUND: Injection drug use-associated endocarditis (IDUaIE) incidence in Ontario has recently been associated with hydromorphone prescribing rates. Staphylococcus aureus causes the majority of cases of IDUaIE in Ontario and across North America. Hydromorphone controlled-release (Hydromorphone-CR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Katherine J., Manoharan, Iswarya, Hallam, Brian, Coleman, Charlotte E., Koivu, Sharon L., Weir, Matthew A., McCormick, John K., Silverman, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688832/
https://www.ncbi.nlm.nih.gov/pubmed/31398210
http://dx.doi.org/10.1371/journal.pone.0219777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688832/
https://www.ncbi.nlm.nih.gov/pubmed/31398210
http://dx.doi.org/10.1371/journal.pone.0219777

Ejemplares similares